Summary
Tricol Biomedical Inc (Tricol Biomedical), formerly HemCon Medical Technologies Inc, a subsidiary of Tricol International Group Ltd, is a medical device company that develops, manufactures and markets hemostasis and infection control products. The company’s products include chitogauze pro and guardacare pro, hemcon guardiva, hemcon patch pro, guardacarexr surgical and hemcon bandages pro. It offers products under the brands OneStop, HemCon, and m.doc. Tricol Biomedical offers its products for use in the treatment of trauma and surgery and dressing products, military medics, paramedics, first responders, and consumers. The company supplies its products through distributors in Europe, Asia-Pacific and the Middle East. Tricol Biomedical is headquartered in Portland, Oregon, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
In this report,
Search for an exact word or phrase by placing the word or phrase in quotation marks ("market trend"). Search for different versions or tenses of a word by placing an asterisk at the end of the word (pharma*).
Please note that your term must be at least three characters long and numbers will be blocked by the # sign.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook